Cover Image

A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib

Saved in:

Bibliographic Details
Main Authors:	Mary Clark, MD (Author), Paul Imbriano, DO (Author), Michael Harwood, MD (Author), Klaus Busam, MD (Author), Leslie Robinson-Bostom, MD (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma
by: Bao D. Dao MD, et al.
Published: (2015)

Use of BRAF inhibitor (Vemurafenib) in a child with Refractory Langerhans cell histiocytosis
by: Anil Sharma, et al.
Published: (2017)

Atypical melanocytic nevi with segmental distribution resembling seborrheic keratoses
by: Laurence Mainville, MD, et al.
Published: (2021)

Delayed-onset vemurafenib-induced panniculitis
by: Stephen L. Vance, MD, MBA, et al.
Published: (2017)

Adult‐onset BRAF V600E‐related multisystem Langerhans cell histiocytosis treated with vemurafenib
by: Lisa Denise A. Encarnacion‐Mangubat, et al.
Published: (2024)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
by: A. S. Kolbin, et al.
Published: (2018)

Congenital melanocytic nevus with scrotal mass: A diagnostic dilemma
by: Tanmay Motiwala, et al.
Published: (2021)

Localized Epidermal Cysts as a Radiation Recall Phenomenon in a Melanoma Patient Treated with Radiotherapy and the BRAF Inhibitor Vemurafenib
by: Carine Houriet, et al.
Published: (2014)

Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function
by: Martin Michaelis, et al.
Published: (2014)

Multiple de novo spitzoid nevi arising within a specific red tattoo ink
by: David I. Latoni, MPH, et al.
Published: (2024)

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question
by: Stefania Federica De Mercanti MD, PhD, et al.
Published: (2020)

Lichen Planus Mimicking Atypical Melanocytic Lesion in a Man With Dark Skin
by: Federica Scarfi, et al.
Published: (2020)

Infarcted neuroendocrine tumor following endobronchial ultrasound guided fine needle aspiration of a pulmonary nodule: Typical versus atypical carcinoid a pathological diagnostic dilemma
by: Sarmad H. Jassim, MD, et al.
Published: (2017)

Eruptive melanocytic nevi with malignant transformations and the connection to BRAF and p16 mutations
by: Ting-Hua Yang, et al.
Published: (2017)

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib
by: Camille Pinard, MD, et al.
Published: (2017)

Hyperspectral Imaging for Non-invasive Diagnostics of Melanocytic Lesions
by: John Paoli, et al.
Published: (2022)

Atypical vascular lesions cleared with Mohs micrographic surgery
by: Jose L. Cortez, MD, MS, et al.
Published: (2024)

COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma
by: Asim Kichloo MD, et al.
Published: (2020)

Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases
by: Christopher C. Hemond MD, et al.
Published: (2021)

Diagnostic Dilemma in the Treatment of a Fatal Case of Bloody Diarrhea
by: Sidharth Mahapatra MD, PhD, et al.
Published: (2016)

Atypical florid vascular proliferation in appendix: a diagnostic dilemma
by: Gu Mi Jin, et al.
Published: (2013)

Targeted therapy with BRAF inhibitor Vemurafenib in relapse/refractory multisystem langerhans cell-retrospective analysis from a tertiary care center in India
by: Purva Kanvinde, et al.
Published: (2021)

Improvement of Neurodegenerative Disease after Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report
by: Young Kwon Koh, et al.
Published: (2022)

FISH as an effective diagnostic tool for the management of challenging melanocytic lesions
by: Gasparini Robert, et al.
Published: (2011)

Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
by: Peter A. Young, MPAS, BS, et al.
Published: (2021)

Dual Lesions: A Diagnostic Dilemma
by: M. P. V. Prabhat, et al.
Published: (2013)

Lesion on palate: A diagnostic dilemma
by: Swati N Chavan, et al.
Published: (2016)

Evaluation of electrical impedance spectroscopy as an adjunct to dermoscopy in short-term monitoring of atypical melanocytic lesions
by: Hannah Ceder, et al.
Published: (2016)

CLINICAL AND ECONOMIC EVALUATION OF ATEZOLIZUMAB + VEMURAFENIB + COBIMETINIB COMBINATION AND NIVOLUMAB + IPILIMUMAB COMBINATION: ADMINISTRATION IN METASTATIC MELANOMA TREATMENT WITH BRAF-CONFIRMED MUTATION IN ADULT PATIENTS
by: I. S. Krysanov, et al.
Published: (2022)

EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF<sup>V600E</sup> Mutated Parent- and Vemurafenib-Resistant Melanoma
by: Yige Fu, et al.
Published: (2019)

BRAF Mutation Heterogeneity in Melanoma Lesions
by: Kaori Sakaizawa, et al.
Published: (2020)

A Case of Complete Heart Block With Diagnostic Challenge and Therapeutic Dilemma
by: Ying Chi Yang MD, et al.
Published: (2018)

Recrudescence of incontinentia pigmenti presenting as a paraneoplastic syndrome: A natural experiment of NF-kB blockade in an inflammatory malignancy
by: Blake Elizabeth Brooks, MD, MS, et al.
Published: (2023)

Melanocytic lesions of the prostate
by: Maria Estela Pompeu do Amaral, et al.
Published: (2020)

Amelanotic melanoma in the vicinity of acquired melanocytic nevi and not arising from agminated melanocytic nevi: Masquerading as pyogenic granuloma
by: Angoori Gnaneshwar Rao, et al.
Published: (2016)

Melanoma arising in a persistent nevus: Melanoma where 'pseudomelanoma' is expected
by: Thomas N. Helm, MD, et al.
Published: (2021)

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
by: Raphael Reinhard, MD, et al.
Published: (2018)

Providencia stuartii septic vasculitis
by: Elisabeth A. George, BA, et al.
Published: (2020)

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF<sup>V600E</sup> Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia
by: Anna Lisa Furfaro, et al.
Published: (2022)

Painless Aortic Dissection-Diagnostic Dilemma With Fatal Outcomes: What Do We Learn?
by: Saeeda Fatima MD, et al.
Published: (2017)